38,061 results on '"Gout"'
Search Results
2. Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
3. Treat-to-target by Email During Urate-lowering Therapy in Gout (GOUTEmail)
4. A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
5. Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation (Ana4CKD)
6. Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination with Allopurinol in Patients with Tophaceous Gout
7. Extension Study of ABP-671 in Participants With Gout
8. Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout
9. A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects
10. Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
11. Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
12. A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)
13. Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
14. Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout
15. Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout (TRUST)
16. Improving Gout Care After an ED Visit (CARE-Gout)
17. The Effect of Tart Cherry Juice on Risk of Gout Attacks
18. Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout (EchoGoutte)
19. Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy
20. Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout (MIRROR RCT)
21. Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout (MIRROR OL)
22. Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant
23. Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare (COMpARE)
24. A Nurse Led Patient Management Programme to Improve Outcomes in Gout (BONUS)
25. Gout Self-Monitoring Aiming to Reach Target (Gout-SMART)
26. Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
27. A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) (FORWARD OL)
28. Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
29. Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
30. UR+AIMS Gout Wearable Skin Uric Acid Monitor Study
31. Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout
32. A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout
33. CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
34. CLinical Prediction Rule Score in Veterans
35. Tahiti-families: Polynesian Families of Gout Patients (Tahiti)
36. Genetic of Chronic Kidney Disease and Gout in New Caledonia (CALEDGOUTCKD)
37. A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
38. The Remote Monitoring of Gout Feasibility Study (ReMonit Gout)
39. A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II (DISSOLVE II)
40. A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy (DISSOLVE I)
41. Prednisolone Versus Colchicine for Acute Gout in Primary Care (COPAGO)
42. Assessment of Physician Consideration of ePRO's, From Patients With Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments (CAPTAIN)
43. Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health.
44. Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulators.
45. The association between triglyceride glucose index and gout: a cross-sectional analysis based on NHANES 2007–2018.
46. Whole-genome sequencing reveals rare variants associated with gout in Taiwanese males.
47. Integrating transcriptomics, eQTL, and Mendelian randomization to dissect monocyte roles in severe COVID-19 and gout flare.
48. Serum ionized magnesium acts as an independent protective factor against bone erosion in patients with gouty arthritis: a cross-sectional study.
49. The burden of rheumatologic disease in Aboriginal and Torres Strait Islander Australians.
50. Downregulation of type I interferon signalling pathway by urate in primary human PBMCs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.